智翔金泰跌2.12% 连亏4年3季2023年上市募34.7亿元

Core Viewpoint - Zhixiang Jintai (688443.SH) has experienced a decline in stock price, currently trading at 30.00 yuan, reflecting a drop of 2.12% and is in a state of breaking issue [1] Group 1: Company Financials - Zhixiang Jintai was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 20, 2023, with an initial public offering of 91.68 million shares at a price of 37.88 yuan per share [1] - The total amount raised from the IPO was 347.28 million yuan, with a net amount of 329.14 million yuan after deducting issuance costs, which is 68.86 million yuan less than the originally planned amount of 398 million yuan [1] - The company has reported losses for four consecutive years and three quarters, with net profits attributable to shareholders of -322 million yuan in 2021, -576 million yuan in 2022, -801 million yuan in 2023, and -797 million yuan in 2024 [2] - For the first three quarters of 2025, Zhixiang Jintai achieved revenue of 208 million yuan, a significant increase of 1,562.05%, but still reported a net loss of -333 million yuan [2] Group 2: Use of Funds - The funds raised from the IPO are intended for the expansion and renovation of the antibody industrialization base project, the second phase of the antibody industrialization base project, research and development of antibody drugs, and to supplement working capital [1]